Table 1 Anti-SARS-CoV2 activity of the isolated compound (Plaque Reduction Assay).
Conc (ng/µl) | Initial viral count (PFU/ml) | Viral count (PFU/ml) | Inhibition % |
|---|---|---|---|
5 | 11 × 105 | 0.55 × 105 | 95 |
2.5 | 0.88 × 105 | 92 | |
1.25 | 1.32 × 105 | 88 | |
0.625 | 1.65 × 105 | 85 |
Conc (ng/µl) | Initial viral count (PFU/ml) | Viral count (PFU/ml) | Inhibition % |
|---|---|---|---|
5 | 11 × 105 | 0.55 × 105 | 95 |
2.5 | 0.88 × 105 | 92 | |
1.25 | 1.32 × 105 | 88 | |
0.625 | 1.65 × 105 | 85 |